TY - JOUR
T1 - How to manage Cushing's disease after failed primary pituitary surgery
AU - Agrawal, Nidhi
AU - Urwyler, Sandrine A.
AU - Mehta, Sonal
AU - Karavitaki, Niki
AU - Feelders, Richard A.
N1 - Publisher Copyright:
© 2024 The Author(s).
PY - 2024/9
Y1 - 2024/9
N2 - The first-line treatment for Cushing's disease is transsphenoidal adenomectomy, which can be curative in a significant number of patients. The second-line options in cases of failed primary pituitary surgery include repeat surgery, medical therapy, and radiation. The role for medical therapy has expanded in the last decade, and options include pituitary-Targeting drugs, steroid synthesis inhibitors, and glucocorticoid receptor antagonists. Bilateral adrenalectomy is a more aggressive approach, which may be necessary in cases of persistent hypercortisolism despite surgery, medical treatment, or radiation or when rapid normalization of cortisol is needed. We review the available treatment options for Cushing's disease, focusing on the second-line treatment options to consider after failed primary pituitary surgery.
AB - The first-line treatment for Cushing's disease is transsphenoidal adenomectomy, which can be curative in a significant number of patients. The second-line options in cases of failed primary pituitary surgery include repeat surgery, medical therapy, and radiation. The role for medical therapy has expanded in the last decade, and options include pituitary-Targeting drugs, steroid synthesis inhibitors, and glucocorticoid receptor antagonists. Bilateral adrenalectomy is a more aggressive approach, which may be necessary in cases of persistent hypercortisolism despite surgery, medical treatment, or radiation or when rapid normalization of cortisol is needed. We review the available treatment options for Cushing's disease, focusing on the second-line treatment options to consider after failed primary pituitary surgery.
UR - http://www.scopus.com/inward/record.url?scp=85204511599&partnerID=8YFLogxK
U2 - 10.1093/ejendo/lvae110
DO - 10.1093/ejendo/lvae110
M3 - Review article
C2 - 39276376
AN - SCOPUS:85204511599
SN - 0804-4643
VL - 191
SP - R37-R54
JO - European Journal of Endocrinology
JF - European Journal of Endocrinology
IS - 3
ER -